Table 7.
Factors included in model construction
| Characteristics | Model 1 | Model 2 | Model 3 |
|---|---|---|---|
| Age (years) | Y | ||
| BMI | Y | ||
| Basal FSH (mIU/mL) | Y | Y | |
| Basal LH (mIU/mL) | Y | Y | |
| Basal P (ng/mL) | Y | ||
| AFC | Y | Y | Y |
| AMH (ng/mL) | Y | Y | |
| LH on HCG day (mIU/mL) | Y | Y | |
| E2 on HCG day (pg/mL) | Y | Y | Y |
| Delta FSH | Y | ||
| Delta LH | Y | Y | |
| Delta E2 | Y | Y | Y |
| Number of follicles ≥ 14 mm on HCG day | Y | Y | Y |
| Total dose of Gn (IU) | Y | Y | |
| Dosing days of Gn (days) | Y | Y | |
| Retrieved oocytes | Y | Y | |
| MII oocytes | Y | Y | |
| 2PN fertilized oocytes | Y | Y | |
| Cleavage embryo | Y | ||
| High-quality cleavage embryo | Y |
M1 and M2 for predicting high-quality cleavage embryos, M3 for predicting high-quality blastocysts
BMI, body mass index; FSH, follicular-stimulating hormone; LH, luteinizing hormone; P, progesterone; E2, estradiol; AFC, antral follicle count; AMH, anti-Müllerian hormone; Gn, gonadotropin; HCG, human chorionic gonadotropin